CRNX compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

CRNXCrinetics Pharmaceuticals, Inc.

XENEXenon Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CRNX 3

—SKKunlistedcustomer

—Loyalunlistedcustomer

—Sanwa Kagaku Kenkyushounlistedcustomer

Shared 0

No shared counterparties.

Only XENE 2

NBIXNeurocrine Biosciencessupplier

BHCBausch Healthsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CRNXCrinetics Pharmaceuticals, Inc.

84.97▲+0.15%· post 84.97· delayed

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

XENEXenon Pharmaceuticals Inc.

37.61▲+0.54%· post 37.01· delayed

After hoursNov 2 '26delayed

Mkt cap$3.6BRevenue$8MQ1 FY25Revenue—

Compare

After hoursNov 2 '26delayed

CRNXCrinetics Pharmaceuticals, Inc.

XENEXenon Pharmaceuticals Inc.

84.97▲+0.15%post 84.97delayed

Price

37.61▲+0.54%post 37.01delayed

$509.7M

Mkt cap

$3.6B

Q2 FY26$25M

Revenue

$8MQ1 FY25

FY25$8M

Revenue

—

CRNX84.97▲+0.15%vsXENE37.61▲+0.54%After hoursNov 2 '26delayed